Etonogestrel implant in women with diabetes mellitus
Authors:
- Lisa VicenteLVLisa Vicente
- Denisa MendonçaDMDenisa Mendonça
- Marina DingleMDMarina Dingle
- Rui DuarteRDRui Duarte
- J. Manuel BoavidaJBJ. Manuel Boavida
- 1 January 2008
- journal article
- Published by Taylor & Francis in The European Journal of Contraception & Reproductive Health Care
- Vol. 13 (4) , 387-395
Abstract
To evaluate the effect of etonogestrel implant on the control of the carbohydrate and lipid metabolism and on the progression of vascular complications in diabetic women treated with insulin, and to assess the acceptability of this modality of contraception in these patients. Prospective-observational study of 23 women with insulin-treated diabetes. Clinical and metabolic evaluation was performed before and at 3, 6, 12, and 24 months after implant insertion. Changes from baseline were compared using the mixed effects models or Wilcoxon matched-pairs signed-rank tests. There were no significant changes in BMI, in daily insulin requirement and in mean HbA1c. There was a significant reduction of total serum cholesterol (TC) at 6 and 12 months, of triglyceride levels at 6, 12 and 24 months, and of high-density lipoprotein cholesterol (HDL-C) at 6, 12 and 24 months. Neither the low-density lipoprotein (LDL) levels nor the HDL/TC ratio changed. Albuminuria decreased significantly at 12 and 24 months. No deterioration of the retina was observed over the study period. Amenorrhoea and infrequent bleeding were the most common menstrual bleeding patterns. One woman discontinued the method due to frequent bleeding. We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of vascular lesions during the two years an etonogestrel implant was used by diabetic women.Keywords
This publication has 25 references indexed in Scilit:
- Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 22006
- ACOG Practice Bulletin No. 73: Use of Hormonal Contraception in Women With Coexisting Medical ConditionsObstetrics & Gynecology, 2006
- Contraceptive Counseling of Diabetic Women of Reproductive AgeObstetrics & Gynecology, 2006
- Contraception in diabetic women: an Italian studyDiabetes Research and Clinical Practice, 2005
- Effect of Implanon® and Norplant® subdermal contraceptive implants on serum lipids—a randomized comparative studyContraception, 2003
- Metabolic effects of implantable steroid contraceptives for womenContraception, 2002
- Implanon® contraceptive implants: effects on carbohydrate metabolismContraception, 2001
- Empfängnisverhütung bei Typ-I-Diabetikerinnen: Eine Erhebung bei 808 Frauen im fertilen AlterGeburtshilfe und Frauenheilkunde, 1994
- Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease riskAmerican Journal of Obstetrics and Gynecology, 1994
- The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate MetabolismNew England Journal of Medicine, 1990